IP Library Granted Patent US 9,295,516
Granted Patent B2
US 9,295,516 · App. 14/147,162 · Granted Mar 29, 2016

Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,295,516
App. No.
14/147,162
Granted
Mar 29, 2016
Kind
B2
Abstract

A method for treating Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis to alleviate the discomforts of breathing by using non-thermal electroporation energy to ablate diseased portions of the lung including the bronchus, airways and alveoli which, in effect, opens the restrictive diseased portions thereby maximizing the overall surface area thereof causing improved airflow and uninhibited breathing.

Claims (25)

1. A method of electrically ablating lung tissue by irreversible electroporation comprising:

accessing a target region of the lung;

positioning an energy delivery device within an airway of the target region of the accessed lung, the energy delivery device having an expandable member and at least one electrode;

expanding the expandable member spa as to bring the electrode closer to the airway of the target region; and

applying electrical pulses through the electrode of the expanded expandable member sufficient to irreversibly electroporate the tissue cells in the target region.

2. The method of claim 1 , wherein the step of accessing includes inserting the energy delivery device through a catheter to the target region.

3. The method of claim 1 , wherein the step of positioning the energy delivery device eludes positioning the energy delivery device within a diseased region of an inner wall of a bronchus of the lung.

4. The method of claim 3 , prior to the step of positioning, further comprising advancing the energy delivery device through a patient's trachea.

5. The method of claim 1 , wherein the step of positioning the energy delivery device includes inserting the energy delivery device within a diseased region of an alveolus of the lung.

6. The method of claim 5 , wherein the step of obtaining access includes obtaining access percutaneously prior to positioning the energy delivery device within the diseased region of the alveolus.

7. The method of claim 1 , wherein:

the energy delivery device has a plurality of uniformly spaced electrodes; and

the step of applying electrical pulses includes applying the electrical pulses using the plurality of electrodes after the expandable member has been expanded.

8. The method of claim 6 , wherein the step of applying electrical pulses includes applying the electrical pulses using a probe having deployable tines as the energy delivery device.

9. The method of claim 3 , wherein the step of positioning positions the energy delivery device endo-bronchially or exo-bronchially.

10. The method of claim 5 , wherein the step of positioning positions the ene delivery device endo-bronchially or exo-bronchially.

11. The method of claim 1 , wherein the step of applying electrical pulses includes applying the electrical pulses in a plurality of pulse trains with each pulse train having at least two pulses.

12. The method of claim 11 , wherein the step of applying electrical pulses includes applying the plurality of pulse trains with a delay of at least 0.5 seconds between two pulse trains.

13. The method of claim 8 , wherein the step of applying electrical pulses includes applying the electrical pulses directly into tissue adjacent the alveoli to ablate the target region to substantially decrease lung volume and increase lung function.

14. The method of claim 7 , wherein:

the electrodes are positioned on the expandable member; and

the step of expanding the expandable member includes expanding a balloon to place the electrodes on the balloon in contact with the inner wall of the bronchus to ablate the target region to substantially increase a diameter of the bronchus.

15. The method of claim 1 , wherein the step of applying electrical pulses includes applying the electrical pulses at an energy field strength in the range of between about 100V/cm to about 10,000V/cm.

16. The method of claim 1 , wherein the step of applying electrical pulses includes applying electrical pulses with each pulse having at least 20 microseconds in length.

17. The method of claim 2 , further comprising retracting the energy delivery device into the catheter and redeploying the catheter into a bronchus of the lung.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2023
From: PEARSON, ROBERT; ORTIZ, MARK; CALLAS, PETER
To: ANGIODYNAMICS, INC.
Reel/Frame 062679/0023 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →